Misvik Biology - About the company
Misvik Biology is a funded company based in Turku (Finland), founded in 2014 by Juha Rantala. It operates as a Provider of precision oncology contract research and toxicology research services. Misvik Biology has raised an undisclosed amount in funding. The company has 154 active competitors, including 39 funded and 18 that have exited. Its top competitors include companies like Crown Bioscience, Scholar Rock and Lucida Medical.
Company Details
Provider of precision oncology contract research and toxicology research services. It offers high-throughput cell panel and ex vivo drug screening services integrated with multiomics analyses. It develops diagnostic technology for precision oncology and assessment of targeted therapies for rare cancers by ex vivo testing of therapy efficacy using patient-derived tumor and immune cells. It provides toxicology research services including integrative omics methods for in vitro NanoToxicology, high-throughput organoid screening, big data integration, and predictive ToxicoGenomic testing.
- Website
- www.misvik.com/
- Social
- Email ID
- *****@misvik.com
Key Metrics
Founded Year
2014
Location
Turku, Finland
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
42nd among 154 active competitors
Employee Count
12 as on Jul 31, 2026
Similar Companies
Sign up to download Misvik Biology's company profile
Misvik Biology's funding and investors
Misvik Biology has raised funding over 7 rounds. Its first funding round was on May 01, 2016. Its latest funding round was a Grant (prize money) round on Mar 01, 2023 for $*****. 1 investor participated in its latest round. Misvik Biology has 1 institutional investor.
Here is the list of recent funding rounds of Misvik Biology:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 01, 2023 | 3569208 | Grant (prize money) | 1023781 | 7083982 | 9599834 | 8210213 |
Feb 01, 2021 | 3265948 | Grant (prize money) | 9242520 | 6528970 | 6826341 | |
Jan 01, 2021 | 7311721 | Grant (prize money) | 9637661 | 3454385 | 1782557 |
Access funding benchmarks and valuations. Sign up today!View details of Misvik Biology's funding rounds and investors
Misvik Biology's founders and board of directors
Founder? Claim ProfileThe founders of Misvik Biology is Juha Rantala. Juha Rantala is the CEO of Misvik Biology.
Here are the details of Misvik Biology's key team members:
- Juha Rantala: Founder & CEO of Misvik Biology.
View details of Misvik Biology's Founder profiles and Board Members
Misvik Biology's employee count trend
Misvik Biology has 12 employees as of Jul 26. Here is Misvik Biology's employee count trend over the years:
Uncover Misvik Biology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Misvik Biology's Competitors and alternates
Top competitors of Misvik Biology include Crown Bioscience, Scholar Rock and Lucida Medical. Here is the list of Top 10 competitors of Misvik Biology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Crown Bioscience 2006, Santa Clara (United States), Acquired | Developer of drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases) | $85.9M | 72/100 | |
2nd | Scholar Rock 2012, Cambridge (United States), Public | Developer of Antibody-based drugs for the treatment of primary myopathies | $103M | 61/100 | |
3rd |  Lucida Medical 2019, Cambridge (United Kingdom), Series A | Developer of MRI-based cancer screening technology using artificial intelligence (AI) | $11.5M | 58/100 | |
4th | SamanTree Medical 2014, Lausanne (Switzerland), Series C | Developer of digital microscopy system for high-resolution imaging of tissue | $57.5M | 58/100 | |
5th | Champion Oncology 1985, Hackensack (United States), Public | Oncology CRO providing preclinical and clinical research services globally | - | 58/100 | |
6th | Oncodesign 1995, Dijon (France), Acquired | Provider of preclinical assessment services for anticancer therapies | $4.71M | 58/100 | |
7th | Developer of diagnostic instruments, reagents, and related software | - | - | 54/100 | |
8th | Perfint Healthcare 2005, Chennai (India), Series D | Developer of solutions for image-guided interventional procedures | $41.5M | 54/100 | |
9th | Ionpath 2014, Menlo Park (United States), Series B | Developer of an imaging platform for tissue biopsies | $18M | 53/100 | |
10th | Developer of therapy-assist CT system for minimally invasive interventions | $8.4M | 52/100 | ||
42nd | Misvik Biology 2014, Turku (Finland), Funding Raised | Provider of precision oncology contract research and toxicology research services | - | 33/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Misvik Biology's competitors? Click here to see the top ones
Misvik Biology's Investments and acquisitions
Misvik Biology has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Misvik Biology
Explore our recently published companies
- Shop Wafi - Jeddah based, 2015 founded, Deadpooled company
- Bixabotanical - Mumbai based, 2015 founded, Unfunded company
- Benhurconstruction - Unfunded company
- Saalfo Tech - Mysuru based, 2016 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Uvtcpl - Mumbai based, 2023 founded, Unfunded company
